| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aptose Biosciences Inc (TO: APS)
APS Technical Analysis
5
| As on 21st Nov 2024 APS STOCK Price closed @ 0.34 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.70 & Strong Sell for SHORT-TERM with Stoploss of 5.66 we also expect STOCK to react on Following IMPORTANT LEVELS. |
APSSTOCK Price
| Open | 0.39 | Change | Price | % |
| High | 0.40 | 1 Day | -0.04 | -10.53 |
| Low | 0.34 | 1 Week | -0.20 | -37.04 |
| Close | 0.34 | 1 Month | -0.15 | -30.61 |
| Volume | 49346 | 1 Year | -0.23 | -40.35 |
| 52 Week High 9.00 | 52 Week Low 0.47 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| ENB | 60.79 | 1.40% |
| CNQ | 48.30 | 2.31% |
| MFC | 45.33 | -1.56% |
| UEX | 0.50 | 16.28% |
| SU | 57.21 | 0.02% |
| CVE | 22.64 | 0.98% |
| SJR-B | 40.48 | 0.02% |
| AC | 23.97 | -2.16% |
| BCE | 37.27 | -1.25% |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| APS Daily Charts |
APS Intraday Charts |
Whats New @ Bazaartrend |
APS Free Analysis |
|
|
APS Important Levels Intraday
| RESISTANCE | 0.46 |
| RESISTANCE | 0.42 |
| RESISTANCE | 0.40 |
| RESISTANCE | 0.37 |
| SUPPORT | 0.31 |
| SUPPORT | 0.28 |
| SUPPORT | 0.26 |
| SUPPORT | 0.22 |
APS Forecast November 2024
| 4th UP Forecast | 6.66 |
| 3rd UP Forecast | 4.63 |
| 2nd UP Forecast | 3.38 |
| 1st UP Forecast | 2.13 |
| 1st DOWN Forecast | -1.45 |
| 2nd DOWN Forecast | -2.7 |
| 3rd DOWN Forecast | -3.95 |
| 4th DOWN Forecast | -5.98 |
APS Weekly Forecast
| 4th UP Forecast | 17.24 |
| 3rd UP Forecast | 11.82 |
| 2nd UP Forecast | 8.47 |
| 1st UP Forecast | 5.12 |
| 1st DOWN Forecast | -4.44 |
| 2nd DOWN Forecast | -7.79 |
| 3rd DOWN Forecast | -11.14 |
| 4th DOWN Forecast | -16.56 |
APS Forecast2024
| 4th UP Forecast | 17.61 |
| 3rd UP Forecast | 12.07 |
| 2nd UP Forecast | 8.65 |
| 1st UP Forecast | 5.22 |
| 1st DOWN Forecast | -4.54 |
| 2nd DOWN Forecast | -7.97 |
| 3rd DOWN Forecast | -11.39 |
| 4th DOWN Forecast | -16.93 |
Aptose Biosciences Inc ( TO Canada Symbol : APS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
APS Business Profile
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia and high-risk myelodysplastic syndrome. It has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806 and CG-806, which are in Phase 1a/b clinical trial for the treatment of patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, and certain non-Hodgkin's lymphomas, as well as relapsed/refractory acute myeloid leukemia. The company also has an agreement with OHM Oncology for the development, manufacture, and commercialization of APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada. Address: 251 Consumers Road, Toronto, ON, Canada, M2J 4R3
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service